Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Neurology
•
Vascular Neurology
•
General Primary Care
•
General Hospital Medicine
Do you prescribe GLP-1 agonists to diabetic patients admitted with minor CVA or TIA for secondary stroke prevention, as suggested by a recent RCT in JAMA Internal Medicine?
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2840370
Related Questions
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?
How do you choose among SSRIs and dosing strategies for the management of behavioral and psychological symptoms of dementia?
When would you consider prescribing a wakefulness promoting agent for excessive daytime sleepiness from insufficient sleep?
When do you consider attributing isolated psychosis to an acute ischemic stroke?
Is there a role for functional medicine approaches in psychiatric treatment?
Would you offer TPO-RAs to a steroid-refractory chronic ITP patient with history of stroke?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
